Emavusertib

DB18060InvestigationalSmall molecule

Emavusertib: Overview.

Chemical structure of Emavusertib
Formula / weight
C24H25N7O5 · 491.508 g/mol (avg)
Also known as
4-oxazolecarboxamide, n-(5-((3r)-3-hydroxy-1-pyrrolidinyl)-2-(4-morpholinyl)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methyl-4-pyridinyl)-
Code names
AU-4948 · CA-4948

Resolves to

Compound
UNIIMH5DMF9JKYCAS1801344-14-8ChEMBLCHEMBL4783351
Structure
InChIKeySJHNWSAWWOAWJH-MRXNPFEDSA-NSMILESCC1=CC(=CC=N1)C1=NC(=CO1)C(=O)NC1=C(N=C2N=C(OC2=C1)N1CCOCC1)N1CC[C@@H](O)C1
Targets
Q9NWZ3IRAK4

What you can answer from here — as of April 02, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Emavusertib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In